2024-514767-26-00已完成1 期
Combining drug-eluting bead chemoembolization and radioembolization for treatment of colorectal liver metastases: DEBIR90Y study
Universitair Medisch Centrum Utrecht1 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2024年8月22日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 15
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（18-64 Years, 65+ Years）
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
Prof. dr. M.G.E.H. Lam
Scientific
Universitair Medisch Centrum Utrecht
研究点 (1)
Loading locations...
相似试验
招募中
不适用
Combining drug-eluting bead transarterial chemoembolisation and radioembolization for treatment of colorectal liver metastases: DEBIR90Y studyColorectal liver metastasesliver metastases from colon and rectal cancer1002747610019818NL-OMON48751niversitair Medisch Centrum Utrecht15
进行中（未招募）
不适用
DEBDOX for liver metastases in breast carcinomaEUCTR2012-000973-22-NL
尚未招募
2 期
Transarterial Chemoembolization with Drug-Eluting Beads Loaded with Doxorubicin for the Treatment of Metastatic Breast Cancer to the Liver: a pilot studyliver metastases breast cancer10027476NL-OMON37702Antoni van Leeuwenhoek Ziekenhuis10
招募中
不适用
TRENDY trialPatients diagnosed with HCC, Child-Pugh grade A, one tumor 𕟮cm, and 󖾆 years old.NL-OMON28819Erasmus MCDepartment of Radiotherapy100
招募中
2 期
Transarterial Chemoembolization with Drug-Eluting Beads (standard arm) versus Stereotactic Body Radiation Therapy (experimental arm) for hepatocellular carcinoma: A multicenter randomized phase II trial *The TRENDY trial*hepatocellular carcinomaNL-OMON44103Erasmus MC, Universitair Medisch Centrum Rotterdam64